Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01926587
Title Oral Rigosertib in Combination With Azacitidine
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Onconova Therapeutics, Inc.

bone marrow cancer

acute myeloid leukemia

chronic myeloid leukemia


Azacitidine + Regorafenib

Age Groups: adult
Covered Countries USA | FRA

No variant requirements are available.